5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.81▼ | 1.81▼ | 1.81▼ | 1.73▲ | 1.76▲ |
MA10 | 1.80▼ | 1.82▼ | 1.81▼ | 1.71▲ | 1.65▲ |
MA20 | 1.81▼ | 1.81▼ | 1.79▲ | 1.77▲ | 1.53▲ |
MA50 | 1.82▼ | 1.75▲ | 1.71▲ | 1.69▲ | 2.79▼ |
MA100 | 1.81▼ | 1.72▲ | 1.73▲ | 1.54▲ | 4.47▼ |
MA200 | 1.75▲ | 1.76▲ | 1.78▲ | 2.33▼ | 3.91▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.007▼ | -0.003▼ | -0.002▼ | 0.141▲ |
RSI | 44.099▼ | 51.178▲ | 58.721▲ | 55.108▲ | 46.562▼ |
STOCH | 50.397 | 31.717 | 48.210 | 49.007 | 69.342 |
WILL %R | -75.000▼ | -83.333▼ | -62.500 | -37.500 | -22.892▲ |
CCI | -8.046 | -75.229 | -13.625 | 94.893 | 63.872 |
CDL | $TCRX Doji Candlestick Pattern Detected | Set Alert |
Friday, August 15, 2025 07:00 AM
NasdaqGM:TCRX 1 Year Share Price vs Fair Value Explore TScan Therapeutics's Fair Values from the Community and ...
|
Tuesday, August 12, 2025 05:14 AM
TScan Therapeutics, Inc. (2) For the three months ended June 30, 2025 and 2024, 73,087,945 and 65,587,945 shares of the Company's voting common stock issuable upon exercise of pre-funded warrants are ...
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.80 | 1.8594 | 1.79 | 1.80 | 189,470 |
14/08/25 | 1.78 | 1.85 | 1.76 | 1.81 | 400,870 |
13/08/25 | 1.74 | 1.7872 | 1.6801 | 1.77 | 267,079 |
12/08/25 | 1.62 | 1.69 | 1.60 | 1.67 | 190,895 |
11/08/25 | 1.62 | 1.645 | 1.60 | 1.61 | 131,176 |
08/08/25 | 1.65 | 1.70 | 1.60 | 1.64 | 146,244 |
07/08/25 | 1.72 | 1.74 | 1.625 | 1.65 | 264,023 |
06/08/25 | 1.77 | 1.78 | 1.68 | 1.73 | 94,881 |
05/08/25 | 1.72 | 1.78 | 1.685 | 1.75 | 215,807 |
04/08/25 | 1.63 | 1.73 | 1.615 | 1.71 | 171,330 |
|
|
||||
|
|
||||
|
|